Total Payments
$21,090
2024 Payments
$2,329
Companies
64
Transactions
936
Medicare Patients
1,430
Medicare Billing
$67,385
Payment Breakdown by Category
Food & Beverage$19,535 (92.6%)
Travel$1,009 (4.8%)
Education$532.79 (2.5%)
Gifts$13.20 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,535 | 893 | 92.6% |
| Travel and Lodging | $1,009 | 5 | 4.8% |
| Education | $532.79 | 37 | 2.5% |
| Gift | $13.20 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,596 | 160 | $0 (2024) |
| ABBVIE INC. | $2,263 | 101 | $0 (2024) |
| Medtronic, Inc. | $2,070 | 39 | $0 (2024) |
| Transenterix, Inc. | $1,553 | 10 | $0 (2020) |
| PFIZER INC. | $1,238 | 75 | $0 (2024) |
| Allergan, Inc. | $1,228 | 109 | $0 (2020) |
| TherapeuticsMD, Inc. | $987.84 | 52 | $0 (2022) |
| Covidien LP | $852.48 | 11 | $0 (2020) |
| Hologic, LLC | $691.99 | 20 | $0 (2022) |
| Lupin Inc. | $626.10 | 27 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,329 | 99 | Medtronic, Inc. ($559.32) |
| 2023 | $2,261 | 86 | Medtronic, Inc. ($760.54) |
| 2022 | $2,200 | 94 | MAYNE PHARMA INC. ($330.96) |
| 2021 | $2,767 | 108 | Novo Nordisk Inc ($551.18) |
| 2020 | $3,326 | 108 | Transenterix, Inc. ($1,278) |
| 2019 | $4,105 | 180 | Novo Nordisk Inc ($605.20) |
| 2018 | $2,465 | 163 | AbbVie, Inc. ($435.21) |
| 2017 | $1,639 | 98 | PFIZER INC. ($253.61) |
All Payment Transactions
936 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Medtronic, Inc. | LIGASURE (Device) | Food and Beverage | In-kind items and services | $148.83 | General |
| Category: Vessel Sealing | ||||||
| 12/18/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $27.47 | General |
| Category: Endocrinology | ||||||
| 12/16/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Neurology | ||||||
| 12/11/2024 | PFIZER INC. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 12/11/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: HORMONE THERAPY | ||||||
| 12/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $9.27 | General |
| Category: Biological | ||||||
| 12/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: PAIN | ||||||
| 11/26/2024 | PFIZER INC. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 11/18/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: Endocrinology | ||||||
| 11/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: Biological | ||||||
| 11/06/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: UROLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $2.07 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: HORMONE THERAPY | ||||||
| 10/31/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: PAIN | ||||||
| 10/25/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: WOMENS HEALTH | ||||||
| 10/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Biological | ||||||
| 10/16/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $30.92 | General |
| 10/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $31.51 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: UROLOGY | ||||||
| 10/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $4.73 | General |
| Category: UROLOGY | ||||||
| 10/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Obesity | ||||||
| 10/07/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Neurology | ||||||
| 10/02/2024 | Evofem Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $20.17 | General |
| 10/01/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: HORMONE THERAPY | ||||||
| 09/25/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 406 | 414 | $61,240 | $19,423 |
| 2022 | 6 | 394 | 404 | $60,262 | $18,856 |
| 2021 | 5 | 341 | 349 | $49,936 | $16,166 |
| 2020 | 5 | 289 | 293 | $42,145 | $12,940 |
Total Patients
1,430
Total Services
1,460
Medicare Billing
$67,385
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 163 | 163 | $18,256 | $6,567 | 36.0% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 138 | 138 | $18,492 | $6,250 | 33.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 28 | $8,932 | $2,043 | 22.9% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 48 | 48 | $7,296 | $1,890 | 25.9% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 16 | 18 | $4,122 | $1,678 | 40.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 19 | $4,142 | $993.78 | 24.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 155 | 155 | $17,360 | $6,152 | 35.4% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 128 | 128 | $17,152 | $5,741 | 33.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 27 | $8,613 | $2,105 | 24.4% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 53 | 53 | $8,056 | $2,051 | 25.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 28 | $6,104 | $1,790 | 29.3% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 12 | 13 | $2,977 | $1,016 | 34.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 144 | 144 | $16,128 | $5,856 | 36.3% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 123 | 123 | $16,482 | $5,621 | 34.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 22 | $7,018 | $1,742 | 24.8% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 42 | 42 | $6,384 | $1,714 | 26.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 18 | $3,924 | $1,233 | 31.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 122 | 122 | $13,664 | $5,016 | 36.7% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 104 | 104 | $13,936 | $4,678 | 33.6% |
| 77080 | Bone density measurement using dedicated x-ray machine | Office | 2020 | 30 | 30 | $4,560 | $1,203 | 26.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 18 | 19 | $6,061 | $1,171 | 19.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 15 | 18 | $3,924 | $871.52 | 22.2% |
About Dr. Christopher Seeker, MD
Dr. Christopher Seeker, MD is a Obstetrics & Gynecology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255349528.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Seeker, MD has received a total of $21,090 in payments from pharmaceutical and medical device companies, with $2,329 received in 2024. These payments were reported across 936 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($19,535).
As a Medicare-enrolled provider, Seeker has provided services to 1,430 Medicare beneficiaries, totaling 1,460 services with total Medicare billing of $67,385. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Austin, TX
- Active Since 08/03/2006
- Last Updated 09/04/2014
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1255349528
Products in Payments
- Senhance Surgical Robotics System (Device) $1,553
- LIGASURE (Device) $1,102
- Ozempic (Drug) $1,002
- Saxenda (Drug) $832.29
- PREMARIN (Drug) $719.48
- SOLOSEC (Drug) $626.10
- UBRELVY (Drug) $610.21
- MYFEMBREE (Drug) $587.61
- LO LOESTRIN FE (Drug) $566.00
- LigaSure (Device) $448.53
- LILETTA (Drug) $415.99
- Autosuture (Device) $410.65
- ANNOVERA (Drug) $327.80
- Veozah (Drug) $324.19
- RYBELSUS (Drug) $312.07
- Wegovy (Drug) $304.83
- Phexxi (Drug) $297.23
- INTRAROSA (Drug) $296.47
- SLYND (Drug) $276.48
- ORILISSA (Drug) $268.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Austin
Devin Garza, M.d, M.D
Obstetrics & Gynecology — Payments: $2.2M
Obstetrics & Gynecology $2.2M
Dr. Shawn Tassone, M.d, M.D
Obstetrics & Gynecology — Payments: $1.4M
Obstetrics & Gynecology $1.4M
Dr. Tomas Antonini, Md, MD
Obstetrics & Gynecology — Payments: $202,682
Obstetrics & Gynecology $202,682
Renu Chalasani, Md, MD
Obstetrics & Gynecology — Payments: $149,207
Obstetrics & Gynecology $149,207
Dr. Saima Jehangir, Md, MD
Obstetrics & Gynecology — Payments: $137,879
Obstetrics & Gynecology $137,879
Amanda White, Md, MD
Obstetrics & Gynecology — Payments: $91,616
Obstetrics & Gynecology $91,616